Glaxo Smith Kline (GSK) with facilities in Collegeville and Valley Forge, reported first half 2018 results, increased their guidance for the remainder of the year and announced a major restructuring program expected to deliver annual cost savings of £400 million by 2021.
{iframe}http://www.wfmz.com/news/southeastern-pa/gsk-announces-major-restructuring-sales-and-earnings-growth/773111688{/iframe}